|
| 36724681 | An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers. | EBioMedicine | 2023 |
| 37291430 | Retraction Note: CCR4 mediates CCL17 (TARC)-induced migration of human colon cancer cells via RhoA/Rho-kinase signaling. | Int J Colorectal Dis | 2023 |
| 37349623 | Diagnostic gastrointestinal markers in primary lung cancer and pulmonary metastases. | Virchows Arch | 2023 |
| 37041522 | Sex and gender differences in treatment intention, quality of life and performance status in the first 100 patients with periampullary cancer enrolled in the CHAMP study. | BMC Cancer | 2023 |
| 37207219 | Expression of Cartilage Oligomeric Matrix Protein in colorectal cancer is an adverse prognostic factor and correlates negatively with infiltrating immune cells and PD-L1 expression. | Front Immunol | 2023 |
| 37140929 | Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution. | Clin Cancer Res | 2023 |
| 37204255 | Correction: Complement inhibitor CSMD1 acts as tumor suppressor in human breast cancer. | Oncotarget | 2023 |
| 37069618 | Imaging ovarian cancer - from baseline characteristics to high-risk image factors. | J Ovarian Res | 2023 |
| 36963351 | Spatial immunophenotyping of the tumour microenvironment in non-small cell lung cancer. | Eur J Cancer | 2023 |
| 34379360 | PRR11 unveiled as a top candidate biomarker within the RBM3-regulated transcriptome in pancreatic cancer. | J Pathol Clin Res | 2022 |
| 35504250 | High Infiltration of CD68+/CD163- Macrophages Is an Adverse Prognostic Factor after Neoadjuvant Chemotherapy in Esophageal and Gastric Adenocarcinoma. | J Innate Immun | 2022 |
| 35660849 | Interplay between Caveolin-1 and body and tumor size affects clinical outcomes in breast cancer. | Transl Oncol | 2022 |
| 35990519 | Expression of cartilage oligomeric matrix protein in periampullary adenocarcinoma is associated with pancreatobiliary-type morphology, higher levels of fibrosis and immune cell exclusion. | Oncoimmunology | 2022 |
| 36316463 | Interaction between blood pressure and genetic risk score for bladder cancer, and risk of urothelial carcinoma in men. | Sci Rep | 2022 |
| 35285182 | The interaction between smoking and bladder cancer genetic variants on urothelial cancer risk by disease aggressiveness. | Cancer Med | 2022 |
| 35312747 | Analytical Validation of a Novel 6-Gene Signature for Prediction of Distant Recurrence in Estrogen Receptor-Positive, HER2-Negative, Early-Stage Breast Cancer. | Clin Chem | 2022 |
| 35149544 | Branching Copy-Number Evolution and Parallel Immune Profiles across the Regional Tumor Space of Resected Pancreatic Cancer. | Mol Cancer Res | 2022 |
| 35109796 | Pre-clinical and clinical studies on the role of RBM3 in muscle-invasive bladder cancer: longitudinal expression, transcriptome-level effects and modulation of chemosensitivity. | BMC Cancer | 2022 |
| 35169225 | Delineating the intra-patient heterogeneity of molecular alterations in treatment-naïve colorectal cancer with peritoneal carcinomatosis. | Mod Pathol | 2022 |
| 34339045 | Infiltration of NK and plasma cells is associated with a distinct immune subset in non-small cell lung cancer. | J Pathol | 2021 |
| 33767994 | Pre- and Postoperative Circulating IGF-I, IGFBP-3, and IGFBP-7 Levels in Relation to Endocrine Treatment and Breast Cancer Recurrence: A Nested Case-Control Study. | Front Oncol | 2021 |
| 33706249 | The prognostic impact of the tumour stroma fraction: A machine learning-based analysis in 16 human solid tumour types. | EBioMedicine | 2021 |
| 33669586 | Human Epidermal Growth Factor Receptor-3 Expression Is Regulated at Transcriptional Level in Breast Cancer Settings by Junctional Adhesion Molecule-A via a Pathway Involving Beta-Catenin and FOXA1. | Cancers (Basel) | 2021 |
| 33805812 | Development of a Novel Weighted Ranking Method for Immunohistochemical Quantification of a Heterogeneously Expressed Protein in Gastro-Esophageal Cancers. | Cancers (Basel) | 2021 |
| 33662273 | Oncogenic translation directs spliceosome dynamics revealing an integral role for SF3A3 in breast cancer. | Mol Cell | 2021 |
| 33634882 | Metabolic factors and the risk of small intestine cancers: Pooled study of 800â¿¿000 individuals in the metabolic syndrome and cancer project. | Int J Cancer | 2021 |
| 33497473 | Clinical significance of RBM3 expression in surgically treated colorectal lung metastases and paired primary tumors. | J Surg Oncol | 2021 |
| 34606580 | Prognostic impact of tumor-specific insulin-like growth factor binding protein 7 (IGFBP7) levels in breast cancer: a prospective cohort study. | Carcinogenesis | 2021 |
| 34158617 | The γ-tubulin meshwork assists in the recruitment of PCNA to chromatin in mammalian cells. | Commun Biol | 2021 |
| 34104541 | T cells, B cells, and PD-L1 expression in esophageal and gastric adenocarcinoma before and after neoadjuvant chemotherapy: relationship with histopathological response and survival. | Oncoimmunology | 2021 |
| 34094928 | The Prognostic Impact of Intratumoral Aryl Hydrocarbon Receptor in Primary Breast Cancer Depends on the Type of Endocrine Therapy: A Population-Based Cohort Study. | Front Oncol | 2021 |
| 32129882 | Quantitative, qualitative and spatial analysis of lymphocyte infiltration in periampullary and pancreatic adenocarcinoma. | Int J Cancer | 2020 |
| 32028050 | WITHDRAWN: Characterization of Patterns of Immune Cell Infiltration in NSCLC. | J Thorac Oncol | 2020 |
| 31900313 | Hypoxia Attenuates Trastuzumab Uptake and Trastuzumab-Emtansine (T-DM1) Cytotoxicity through Redistribution of Phosphorylated Caveolin-1. | Mol Cancer Res | 2020 |
| 32080761 | Re-evaluation of HER2 status in 606 breast cancers-gene protein assay on tissue microarrays versus routine pathological assessment. | Virchows Arch | 2020 |
| 31913660 | Diagnostic Value of Insulinoma-Associated Protein 1 (INSM1) and Comparison With Established Neuroendocrine Markers in Pulmonary Cancers. | Arch Pathol Lab Med | 2020 |
| 31942071 | Tertiary lymphoid structures improve immunotherapy and survival in melanoma. | Nature | 2020 |
| 33194593 | Tumor-Associated CD68<sup>+</sup>, CD163<sup>+</sup>, and MARCO<sup>+</sup> Macrophages as Prognostic Biomarkers in Patients With Treatment-Naïve Gastroesophageal Adenocarcinoma. | Front Oncol | 2020 |
| 33042546 | Lymphocyte antigen 6 superfamily member D is a marker of urothelial and squamous differentiation: implications for risk stratification of bladder cancer. | Biomark Res | 2020 |
| 33176848 | CYP27A1 expression is associated with risk of late lethal estrogen receptor-positive breast cancer in postmenopausal patients. | Breast Cancer Res | 2020 |
| 33004351 | A Functional Genomic Screen Identifies the Deubiquitinase USP11 as a Novel Transcriptional Regulator of ERα in Breast Cancer. | Cancer Res | 2020 |
| 32850390 | Patient Characteristics Influence Activated Signal Transducer and Activator of Transcription 3 (STAT3) Levels in Primary Breast Cancer-Impact on Prognosis. | Front Oncol | 2020 |
| 32958605 | Human G-MDSCs are neutrophils at distinct maturation stages promoting tumor growth in breast cancer. | Life Sci Alliance | 2020 |
| 33013928 | Topographical Distribution and Spatial Interactions of Innate and Semi-Innate Immune Cells in Pancreatic and Other Periampullary Adenocarcinoma. | Front Immunol | 2020 |
| 32587323 | Additive clinical impact of epidermal growth factor receptor and podocalyxin-like protein expression in pancreatic and periampullary adenocarcinomas. | Sci Rep | 2020 |
| 32923173 | Complement inhibitor factor H expressed by breast cancer cells differentiates CD14<sup>+</sup> human monocytes into immunosuppressive macrophages. | Oncoimmunology | 2020 |
| 32145749 | Ovarian cancer subtypes and survival in relation to three comprehensive imaging parameters. | J Ovarian Res | 2020 |
| 32145253 | Inflammatory macrophage derived TNFα downregulates estrogen receptor α via FOXO3a inactivation in human breast cancer cells. | Exp Cell Res | 2020 |
| 32522170 | LGR5 in breast cancer and ductal carcinoma in situ: a diagnostic and prognostic biomarker and a therapeutic target. | BMC Cancer | 2020 |
| 32238929 | Author Correction: Tertiary lymphoid structures improve immunotherapy and survival in melanoma. | Nature | 2020 |